Belgopharma SRL
Belgopharma reported total assets of €3.63m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jul 2026).
The score of Belgopharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +507 % Total assets +113 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Belgopharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jul 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 25 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Belgopharma's financial analysis
- Solvency73.6%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Belgopharma
Belgopharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0762.935.682
- VAT number
- BE0762935682
- Peppol
- Registered · 0208:0762935682 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Feb 2021
- Registered office
- 1070 Anderlecht
- Latest accounts
- 2025 · filed on 22 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Belgopharma (SRL) has been based in Anderlecht since 2021, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 412,067 € and equity of €2.67m; its revenue is not published. Its solvency stands at 73.6%, above the median of its sector (32.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Belgopharma
Companies in the same business, of comparable size and area, outside its group.
- Immed Benelux Wholesale of pharmaceutical and medical goods Uccle · balance sheet €2.74m
- Denta Wholesale of pharmaceutical and medical goods Kontich · balance sheet €5.16m
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
Frequently asked questions about Belgopharma
What is the revenue of Belgopharma?
Belgopharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Belgopharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0762935682 for Belgopharma, if the company is VAT-registered. Its company number (CBE) is 0762.935.682.
Where is the registered office of Belgopharma?
According to the CBE register, the registered office of Belgopharma is in 1070 Anderlecht.
What is the equity of Belgopharma?
At the close of the 2025 financial year, the equity of Belgopharma amounts to 2,674,640 €, a solvency of 73.6% of total assets.
Who manages Belgopharma?
The register lists 1 active mandates at Belgopharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Belgopharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →